myeloprotective
Showing 1 - 6 of 6
Advanced Squamous Non-Small-Cell Lung Cancer Trial (Trilaciclib, Carboplatin, Paclitaxel)
Not yet recruiting
- Advanced Squamous Non-Small-Cell Lung Cancer
- Trilaciclib
- +3 more
- (no location specified)
Jun 11, 2023
Breast Tumors Trial in Guangzhou (Trilaciclib, Epirubicin, Cyclophosphamide)
Not yet recruiting
- Breast Neoplasms
- Trilaciclib
- +7 more
-
Guangzhou, Gangdong, ChinaSun-yat sen university cancer center
Jul 30, 2023
Triple Negative Breast Cancer Trial in United States (Trilaciclib, Sacituzumab Govitecan-hziy)
Recruiting
- Triple Negative Breast Cancer
- Trilaciclib
- Sacituzumab Govitecan-hziy
-
Chandler, Arizona
- +21 more
Oct 25, 2022
Triple Negative Breast Cancer, Breast Cancer Trial in United States (Trilaciclib, Cylophosphamide, Doxorubicin)
Active, not recruiting
- Triple Negative Breast Cancer
- Breast Cancer
- Trilaciclib
- +5 more
-
Los Alamitos, California
- +6 more
Jan 25, 2023
TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)
Active, not recruiting
- TNBC - Triple-Negative Breast Cancer
- Breast Cancer
- Trilaciclib
- +3 more
-
Birmingham, Alabama
- +111 more
Oct 25, 2022
Triple Negative Breast Tumors Trial in Poland (Palbociclib, Paclitaxel, Carboplatin)
Not yet recruiting
- Triple Negative Breast Neoplasms
- Palbociclib
- +2 more
-
Wrocław, Dolnośląskie, Poland
- +5 more
Oct 4, 2021